Anda Inc.

Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals.
Pediatrics Week; 12/19/2009; 1064 words; ...Pharmaceuticals USA, Inc. for infringement of...New Drug Application (ANDA) filed by Teva seeking...infringed by the proposed Teva ANDA product ," said Jerry...FDA approval of the Teva ANDA until the earlier of entry...Administration, Cephalon Inc. This article was prepared...

SCOLR Pharma, Inc. Licenses Dietary Supplements.
Biotech Week; 12/16/2009; 963 words; ...current (see also Scolr Pharma, Inc.). Stephen J. Turner, SCOLR Pharma, Inc.'s Chief Executive Officer...August the Company amended the ANDA relating to its extended release...Therapy, Treatment, Scolr Pharma Inc. This article was prepared by...

Depomed Files Patent Infringement Lawsuit Against Lupin Limited.
Biotech Week; 12/16/2009; 892 words; ...Lupin Pharmaceuticals, Inc., for infringement of...see also Depomed, Inc.). The lawsuit is in...New Drug Application (ANDA) filed by Lupin with...from approving Lupin's ANDA for 30 months or until...Biotechnology, Depomed Inc., Drug Development...

Watson Files FDA Application for Generic Rozerem.
Biotech Week; 12/16/2009; 740 words; Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading...subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug...also Watson Pharmaceuticals, Inc.). Takeda Pharmaceutical Company...

Pennystockchaser.com: www.pennnystockchaser.com: Penny Stock Chaser Alerts, December 11, 2009: GHDX, NETL, MYL and CELG.
M2 Presswire; 12/11/2009; 1733 words; ...December 11, 2009 Mylan Inc. (Nasdaq: MYL) trading at...PITTSBURGH, Dec 11, 2009 -- Mylan Inc. (Nasdaq: MYL) today announced...subsidiary Mylan Pharmaceuticals Inc. received final approval from...Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets...